Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 50 and 70 years of age, of any gender
- People with a body mass index (a measure of body weight relative to height) between 25 and 30
- People with type 2 diabetes whose blood sugar control measure (HbA1c) is at or below 7%
- People with prediabetes whose blood sugar control measure (HbA1c) is at or below 6.5%
- People without diabetes (controls) whose blood sugar control measure (HbA1c) is at or below 5.7%
- People who have signed the study information and consent form
- People who have signed the data processing consent form
Who may not be able to join:
- People taking certain cholesterol-lowering medications, including ezetimibe, fenofibrate, omega-3 fatty acids, or similar drugs that affect how the body processes fats
- People with long-term kidney disease where kidney function has been significantly reduced for 3 months or more
- People whose excess body weight is caused by another underlying medical condition or a genetic syndrome
- People who are currently on insulin therapy
- People with any ongoing or recent health conditions that the study investigators believe could affect the results (confirm with trial site)
- People who have been hospitalised for a serious illness or major surgery within the last 6 months
- People whose current medications have not been at a stable dose for at least 3 months
- People who are allergic or intolerant to any ingredient in the test meal used during the study
- People who are pregnant or breastfeeding
- People who regularly drink more than 20 grams of alcohol per day (for females) or more than 30 grams per day (for males), or who are unwilling to avoid alcohol during the study preparation period
- People who do not wish to give their consent to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Angelina Passaro, Degree in Medicine and Surgery, University Hospital of Ferrara "Sant'Anna"
Phone: +39 3348330516
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Triglyceride concentrations after oral fat loading test; Progression from prediabetes to type 2 diabetes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.